Okamoto K - Search Results

1

E2F5 as an independent prognostic factor in esophageal squamous cell carcinoma.

Ishimoto T, Shiozaki A, Ichikawa D, Fujiwara H, Konishi H, Komatsu S, Kubota T, Okamoto K, Nakashima S, Shimizu H, Nako Y, Kishimoto M, Otsuji E. Ishimoto T, et al. Among authors: okamoto k. Anticancer Res. 2013 Dec;33(12):5415-20. Anticancer Res. 2013. PMID: 24324077

2

Results of combined complete removal of directly invaded organs with the stomach in patients with advanced gastric cancer.

Otsuji E, Sawai K, Yamaguchi T, Hagiwara A, Okamoto K, Kobayashi S, Yamagishi H. Otsuji E, et al. Among authors: okamoto k. Hepatogastroenterology. 2002 Nov-Dec;49(48):1731-3. Hepatogastroenterology. 2002. PMID: 12397780

3

[Detection of sentinel lymphatic region with activated carbon particles in lymph node dissection for colorectal cancer].

Toma A, Hagiwara A, Otsuji E, Okamoto K, Kuriu Y, Ito T, Shimomura K, Takagi T, Takemura M, Fujiyama J, Yamagishi H. Toma A, et al. Among authors: okamoto k. Gan To Kagaku Ryoho. 2002 Nov;29(12):2291-3. Gan To Kagaku Ryoho. 2002. PMID: 12484057 Japanese.

4

[Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of advanced rectal cancer, when surgical treatment was contraindicated].

Kin S, Nakase Y, Fukuda K, Ito T, Shimomura K, Takagi T, Toma A, Fujiyama J, Okamoto K, Sakakura C, Otsuji E, Kitamura K, Itoi H, Hagiwara A, Yamagishi H. Kin S, et al. Among authors: okamoto k. Gan To Kagaku Ryoho. 2002 Nov;29(12):2413-5. Gan To Kagaku Ryoho. 2002. PMID: 12484088 Japanese.

5

Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.

Yata Y, Otsuji E, Okamoto K, Tsuruta H, Kobayashi S, Toma A, Yamagishi H. Yata Y, et al. Among authors: okamoto k. Hepatogastroenterology. 2003 Jan-Feb;50(49):80-4. Hepatogastroenterology. 2003. PMID: 12629996

6

Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate.

Otsuji E, Tsuruta H, Toma A, Kobayashi S, Okamoto K, Yata Y, Yamagishi H. Otsuji E, et al. Among authors: okamoto k. Hepatogastroenterology. 2003 Mar-Apr;50(50):380-4. Hepatogastroenterology. 2003. PMID: 12749227

7

Tumor recurrence and its timing following curative resection of early gastric carcinoma.

Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Hagiwara A, Yamagishi H. Otsuji E, et al. Among authors: okamoto k. Anticancer Res. 2003 Jul-Aug;23(4):3499-503. Anticancer Res. 2003. PMID: 12926097

8

Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma.

Otsuji E, Matsumura H, Okamoto K, Toma A, Kuriu Y, Ichikawa D, Hagiwara A, Yamagishi H. Otsuji E, et al. Among authors: okamoto k. J Surg Oncol. 2003 Nov;84(3):160-5. doi: 10.1002/jso.10311. J Surg Oncol. 2003. PMID: 14598360

9

Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis.

Ochiai T, Sonoyama T, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ueda Y, Otsuji E, Itoi H, Hagiwara A, Yamagishi H. Ochiai T, et al. Among authors: okamoto k. J Cancer Res Clin Oncol. 2004 Apr;130(4):197-202. doi: 10.1007/s00432-003-0533-8. Epub 2004 Feb 10. J Cancer Res Clin Oncol. 2004. PMID: 14770307

10

Postoperative complications following gastrectomy for gastric cancer during the last decade.

Ichikawa D, Kurioka H, Yamaguchi T, Koike H, Okamoto K, Otsuji E, Shirono K, Shioaki Y, Ikeda E, Mutoh F, Yamagishi H. Ichikawa D, et al. Among authors: okamoto k. Hepatogastroenterology. 2004 Mar-Apr;51(56):613-7. Hepatogastroenterology. 2004. PMID: 15086217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,471 results

Search Page

Filters